Kamakura, Japan

Nana Hareyama

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2014.


% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nana Hareyama

Introduction

Nana Hareyama is a notable inventor based in Kamakura, Japan. She has made significant contributions to the field of therapeutic agents, particularly in addressing urine collection disorders. Her innovative work has the potential to improve the quality of life for many individuals suffering from these conditions.

Latest Patents

Hareyama holds a patent for a therapeutic agent or preventive agent for urine collection disorder. This agent is effective in treating urine storage disorders by alleviating side effects associated with anticholinergic actions while also providing analgesic effects. The formulation includes a cyclohexane derivative, a pharmaceutically acceptable salt, or a prodrug, showcasing her expertise in pharmaceutical innovation.

Career Highlights

Nana Hareyama is currently employed at Toray Industries, Inc., where she continues to develop her research and innovations. Her work at this esteemed company highlights her commitment to advancing medical therapies and improving patient outcomes.

Collaborations

Hareyama collaborates with talented colleagues, including Satoru Yoshikawa and Kaoru Nakao. These partnerships enhance her research efforts and contribute to the development of effective therapeutic solutions.

Conclusion

Nana Hareyama's contributions to the field of therapeutic agents demonstrate her dedication to innovation and improving healthcare. Her patent for a therapeutic agent for urine collection disorders is a testament to her impactful work in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…